Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06554652 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06554652 · ClinicalTrials.gov record · last posted 2026-02-27

Selective Neck Dissection Versus Modified Neck Dissection in PTC

StatusRecruiting
PhasePhase 3
Started2024-11-19
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
This study is a phase III, randomized controlled, open label non inferiority study. Patients who meet the inclusion criteria are randomly assigned 1:1 to either the experimental group (selective neck dissection) or the control group (modified neck dissection), with LRFS as the primary endpoint. The aim of the study is to evaluate the safety of selective neck dissection in papillary carcinoma with limited number of lymph node metastases in the lateral neck, and the quality of life compared with modified neck dissection.

Amendment record 2 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 2 times since 2024-08-14; most recent amendment 2026-02-26. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2026-02-26
Status change Not Yet Recruiting→Recruitingv2
Trial Details
NCT Number NCT06554652
Lead Sponsor Fudan University
Conditions Thyroid Cancer
Enrollment 250 participants
Start Date 2024-11-19
Primary Completion 2029-06-30 (estimated)
Study Completion 2029-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-27